Workflow
华绿生物股价跌5.01%,中信保诚基金旗下1只基金重仓,持有202.13万股浮亏损失157.66万元

Group 1 - Core viewpoint: Hualu Bio experienced a 5.01% decline on August 27, with a stock price of 14.80 yuan per share and a total market capitalization of 1.779 billion yuan [1] - Company overview: Jiangsu Hualu Bio-Tech Group Co., Ltd. was established on June 8, 2010, and listed on April 12, 2021. The company specializes in the research, industrial cultivation, and sales of edible mushrooms [1] - Revenue composition: The main business revenue is derived from enoki mushrooms (69.15%), king oyster mushrooms (25.44%), maitake mushrooms (2.65%), other products (1.50%), and cordyceps flowers (1.26%) [1] Group 2 - Major shareholder: CITIC Prudential Fund's multi-strategy mixed fund (LOF) A (165531) increased its holdings by 1.2423 million shares in the second quarter, holding a total of 2.0213 million shares, which represents 2.18% of the circulating shares [2] - Fund performance: The fund has achieved a return of 41.61% year-to-date, ranking 893 out of 8194 in its category, and an annual return of 80.96%, ranking 656 out of 7963 [2] - Fund manager details: The fund manager Jiang Feng has a tenure of 5 years and 137 days, with a total asset scale of 5.782 billion yuan, while Wang Ying has a tenure of 8 years and 195 days, managing 3.835 billion yuan [3]